Amedisys, Inc. (AMED) Thwomps Q2 Profit Views
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $91.05 -0.12%
Revenue Growth %: +1.6%
Financial Fact:
Equity in earnings from unconsolidated joint ventures: 3.24M
Today's EPS Names:
CP, RUSHA, SEIC, More
Revenue Growth %: +1.6%
Financial Fact:
Equity in earnings from unconsolidated joint ventures: 3.24M
Today's EPS Names:
CP, RUSHA, SEIC, More
Join SI Premium – FREE
Amedisys, Inc. (NASDAQ: AMED) reported Q2 EPS of $0.25, $0.21 better than the analyst estimate of $0.04. Revenue for the quarter came in at $305 million versus the consensus estimate of $298.9 million.
For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- Bok Financial Corp (BOKF) Misses Q1 EPS by 27c
- Greene County Bancorp, Inc. (GCBC) Reports Q3 EPS of $0.34
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
